Disease X: CEPI and University of Oxford Collaborate on Rapid Response Vaccine Technology Medical Countermeasures August 29, 2023 …
Research Ramps Up to Mitigate Surging Syphilis Rates in the U.S. Infectious Diseases August 29, 2023 …
Chikungunya Vaccine: Health Canada Moves Forward with Valneva Review Medical Countermeasures August 29, 2023 …
Allucent Awarded BARDA Contract to Accelerate Next-Generation COVID-19 Booster Vaccines Medical Countermeasures August 28, 2023 …
NIAID Study Shows Low-Dose Marburg Vaccine Effective in Macaques Medical Countermeasures August 25, 2023 …
Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus Industry News August 24, 2023 …
Project NextGen: HHS Awards $1.4B for COVID Countermeasure Development Contracts + Grants August 22, 2023 …
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine Medical Countermeasures July 20, 2023 …
DARPA Selects Teams to Develop Vaccine Durability Prediction Model Medical Countermeasures January 13, 2023 …
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding Industry News January 12, 2023 …
Texas Biomed at Forefront of Sudan ebolavirus Vaccine Development Medical Countermeasures December 27, 2022 …
Bavarian Nordic Awarded DoD Contract to Advance Equine Encephalitis Virus Vaccine Medical Countermeasures December 22, 2022 …
Los Alamos Researchers to Help Revolutionize Future of Vaccine Development Medical Countermeasures November 3, 2022 …
NIH Begins Clinical Trial of Intradermal Monkeypox Vaccine Delivery to Expand Supply Medical Countermeasures September 8, 2022 …
Bavarian Nordic to Supply Additional Monkeypox Vaccine to EU Member States Industry News September 7, 2022 …
Mount Sinai Announces the Formation of Clinical-Stage Infectious Diseases Company CastleVax Industry News August 9, 2022 …
New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections Medical Countermeasures July 17, 2022 …
